You are here

Behçet hastalığı: etioloji ve patogenez

Behçet's disease : etiology and pathogenesis

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Behçet's disease ıs a chronic, multisyslemic. relapsing inflammatory syndrome with mucocutaneous, ocular, cardiovascular, rheumatologic, neurologic, gastrointestinal, and pulmonary involvement. The etiology of the disease is unknown. However, many studies have been conducted regarding the etiology and pathogenesis of the disease. In this article, the literature about the etiopathogenesis of Behçet 's disease is reviewed, and recent advances are emphasized/Journal of Turgut (hal Medical Center 2(1 ):~2- . 1995 /
Abstract (Original Language): 
Behçet hastalığı mukokütanöz, oküler, kardiovaskü/er. romalolojik. nörolojik, gastrointestinal ve pulmoner tutulumla seyredehilen kronik, multisistemik. tekrar/ayıcı in/Jamaluar bir sendromdur. Hastalığın etiolojisi bilinmemektedir. Bununla birlikte, hastalığın etiolojisi ve />atogene:i ile ilgili birçok çalışma sürmektedir. Bu derlemede, Behçet hastalığının etiopatogenezı ile ilgili literatür gözden geçirilmiş, hastalığa ait son gelişmelerin belirtilmesi amaçlanmıştır. /Turgut Özal Tıp Merkezi Dergisi 2(1): "2- . IW5/
72-77

REFERENCES

References: 

1 Feigenbaum A Description of Behçet's syndrome in the Hippocratic third book of endemic diseases Br J Ophthalmol 195b; 40:155-7.
2 Behçet H Uber rezıdivıerende aphthose. durch em Virus verursachte Geschwure am Mund. am Auge und an den Genitalien. Dermatol Wochenschr 1937; 105 1152-7
3 Shmuzii T. Ehrlich GE. Inaba G. Hayashi K Behçet's disease (Behçet's syndrome) Semin Arthritis Rheum 1979; 8:223-60.
4 Jankowski J, Crombie 1. Jankowski R. Behçet's syndrome in Scotland Postgrad Med J1992; 68:566-70.
5 Yurdakul S, Günaydın I. Tüzün Y. Tankurt N. Pazarlı H, Özyazgan Y. Yazıcı H The prevalence of Behçet's syndrome in a rural area in northern Turkey J Rheumatol 1988; 15:820-2.
6 O'Duffy JD Summary of international symposium on Behçet's disease J Rheumatol 1978; 5:229-33.
7 O'Duffy JD Behçet's syndrome N Eng J Med 1990; .322:326-8.
8. James DG. 'Silk Route Disease' (Behçet's disease) West J Med 1988; 148:433-7.
9 Chajek T, Fainaru M Behçet's disease Report of 41 cases and a review of the literature. Medicine 1975; 54:1 79-96.
10 Lang BA, Laxer RM. Thorner P. Greenberg M. Silverman ED Pediatric onset of Behçet's syndrome with myositis: Case report • and literature review illustrating unusual features* Arthritis Rheum 1990; 33:418-25
11 Mizuki N. Ohno S. Tanaka H, Seki T. Mizukı N. Kera J. Inaba G. Tsuji K, lnoko H. Association of HLA-B5I and lack of association of class II alleles with Behçet's disease Tissue Antigens 1992; 40:22-30.
12. Lehner T. Batchelor JR. Challacombe SJ, Kennedy L An linmunogenetic basis for the tissue involvement in Behçet's syndrome Immunology 1979; 37:895-900.
13 Sun A. Lin SC. Chu CT. Chiang CP HLA-DR and DO antigens in Chinese patients with Behçet's disease J Oral Pathol Med 1993; 22:60¬3.
14 Denman AM. Fialkow PJ, Pelton BK, Salo AC, Appleford DJ. Gilchrist C Lymphocyte abnormalities in Behçet's syndrome Clin Exp Immunol 1980; 42:175-85.
15 Hussain L. Ward RG, Barnes M. Lehner T Antibodies to herpes simplex virus in polyethylene glycol precipitable complexes and in sera from patients with Behçet's disease. In: Lehner T. Barnes CG, editors. Recent advances in Behçet's disease. London: Royal Society of Medicine Services, 1986: 73-7.
16 Studd M, McCance DJ. Lehner T. Detection of HSV-I DNA in patients with Behçet's syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction. J Med Microbial 1991; 34:39-4.3
17 Hamzaoui K. Ayed K., Slim A. Haniza M, Touraine J Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease. Clin Exp Immunol 18. Resegotti L, Pistone M. Acyclovir and Behçet's syndrome. Ann Intern Med 1984; 100:319
19. Denman AM, Pelton BK, Hylton W, Palmer RG, Topper R. Herpes simplex virus and the rheumatic diseases. Rheumatol Int 1989, 9:143-6.
20. Yokota K, Hayashi S, Fuji N, Yoshikawa K, Kotake S, Isogai E, Ohno S, Arakı Y, Oguma K. Antibody response to oral streptococci in Behçet's disease. Microbiol Immunol 1992; 36.815-22
21. Mizushima Y (The Behçet's disease research committee of Japan). Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease- A multicenter study. J Rheumatol 1989; 16:506-11.
22. Isogai E, Isogai H, Yoshikawa K, Sasamoto Y, Ohno S, Fujii N, Yokota K, Yamaguchi M, Oguma K In vitro model for streptococcus sanguis adherence properties. In: O'Duffy JD, Kökmen E editors. Behçet's disease basic and clinical aspects. New York, Marcel Dekker. 1991: 439-48.
23. Lehner T, Lavery E. Smith R, van der Zee R, Mızushima Y, Shinnick T Association between the 65-Kilodalton heat shock protein, streptococcus sanguis, and the corresponding antibodies in Behçet's syndrome. Infect Imnum 1991;59:1434-41.
24. Mizushima Y. Streptococcus and Behçet's disease. In: O'Duffy JD. Kökmen E editors. Behçet's disease basic and clinical aspects. New York, Marcel Dekker. 1991: 421-6.
25Klok AM, de Vries J, Rothova A, Zaal MJM, Schweitzer CMC, Bos JD, Kijlstra A Antibodies against ocular and oral antigens in Behçet's disease associated with uveitis. Curr Eye Res 1989;8:957-62.
26. Michelson JB, Chisari FV. Behçet's disease. Surv Ophthalmol 1982; 26:190-203.
27. Lehner T, Fortune F, Lavery E, Studd M. Recent advances in T-cell immunoregulation and in the microbial causes of Behçet's disease. In. O'Duffy JD, Kökmen E editors. Behçet's disease basic and clinical aspects. New York, Marcel Dekker 1991. 463-73.
28. Hamza M, Ayed K, Maknı S. Acquired and transitory selective IgA deficiency in Behçet's disease. In: O'Duffy JD, Kökmen E editors Behçet's disease basic and clinical aspects New York, Marcel Dekker. 1991: 365-7.
29. Nabik I, Abdou H, Schumacher R. Behçet's
disease Possible role of secretory component deficiency, synovial inclusions and fibrinolytic abnormality in the various manifestations of the disease J Lab Clin Med 1978; 91409-22
30 Zoubouhs CC, Buttner P, Tebbe B, Orfanos CE Anticardiolipin antibodies in Adamantiades-Behcet's disease Br J Dermatol 1993; 128:281-4.
31. Ahmed AR. Lymphocyte studies in Behçet's syndrome Dermatologica 1982; 164:175-80.
32 Haini S, Mekori T, Sobel JD, Robinson E Aspects of lymphocyte function in Behçet's disease Dermatologica 1976.153.34-7
33. Gupta RC. O'Duffy JD, McDuffie FC. Circulating immune complexes in active Behçet's disease. Clin Exp Immunol 1978; 34:213-8
34. James DG. Behçet's syndrome. N Eng J Med 1979; 301:431-2.
35,Stratigos AJ, Laskaris G, Stratigos JD. Behçet's disease. Semin Neurol 1992; 12:346-57.
36. Lim SD, Haw CR. Kim Nl, Fusaro RM Abnormalities of T-cell subsets in Behçet's syndrome. Arch Dermatol 1983; 119:307-10.
37 Hamzaoui K, Ayed K, Hamza M, Touraine JL Natural killer cells in Behçet's disease. Clin Exp Immunol 1988; 71:126-31
38. Kalian A, Hamzaoui K, Ayed K Abnormalities of T lymphocyte subsets in Behçet's disease demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies. J Rheumatol 1992; 19:742-6.
39. Kaneko F, Takahashi Y, Muramatsu R, Adachi K, M i ura Y, Nakane A, Minagawa T Natural killer cell numbers and Junction in peripheral lymphoid cells in Behçet's disease. Br J Dermatol 1985; 113:313-8.
40. Suzuki Y, Hoshi K. Matsuda T, Mızushima Y Increased peripheral blood +T cells and natural killer cells in Behçet's disease J Rheumatol 1992; 19:588-92
41Sakane T, Suzuki N, Ueda Y. Takada S. Murakawa Y, Hoshino T. Niwa, Y, Tsunematsu T. Analysis of interleukin -2 activity in patients with Behçet's disease Arthritis Rheum 1986; 29:371-8.
42. Akoğltı TF, Direskenelı H, Yazıcı H, Lawrence R TNF, soluble IL-2R and soluble CD-8 m Behçet's disease J Rheumatol 1990; I 7:1 107-8
43. Hamzaoui K. Hamza M. Ayed K Production of TNF-alfa and 1L-1 in active Behçet's disease J Rheumatol 1990; 17: 1428-9
44 Hirohata S, Oka H. Mizushima Y Streptococcal-related antigens stimulate production of IL6 and
76
Journal of Turgut Özal Medical Center 2(1): 1995
Oranı ve ark.
liehçel 's
disease
etiology anıl pathogenesis
interferon - gamına by T cells from patients with Behçet's disease Cell Immunol 1092. 140:410-9
45 Hampton KK. Chamberlain MA. Menon DK. Davıes JA. Coagulation and fibrinolytic activity in Behçet's disease Thromb Haemostas 1991. 06:292-294.
46 Doğan P. Doğan M. Klockenkamper R Determination of trace elements in blood serum of patients with Behçet's disease by total reflection X-ray fluorescence analysis. Clin Chem 1993; 39; 10.37-41
47 Shinuzu K., Ishikawa S, Miyata M, Yoshıda H, Kuba H Relationships between the changes of serum copper levels and ocular attacks in Behçet's disease (an etiological consideration). Excerpta Med Int Congr Ser 1979. 467:61-5.
4S Cengiz K. Giirkaynak F Serum zinc, copper and magnesium in Behçet's disease. In: Lehner T.Barnes CG editors Recent advances in Behçet's disease. London, Royal Society of Medicine Services. 1985: 83.
49 Michelson JB, Friedlaender MH. Behçet's disease Int Ophthalmol Clin 1990; 30:271-8.
50 Aydıntuğ AO. Tokgöz G. D'Cruz DP, Gürler A, Cervera R, Düzgün N, Atmaca LS, Khamashta MA, Hughes GRV. Antibodies to endothelial cells in patients with Behçet's disease. Clin Immunol Inmumopathol 1993; 67:157-62.
51. Jorizzo JL, Solomon AR, Zanolli MD, Leshin B Neutrophilic vascular reactions. J Am Acad Dermatol 1988; 19:983-1005.

Thank you for copying data from http://www.arastirmax.com